| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.6M | +12.8% | -83.7% |
| Cost of Revenue | $3.7M | +9.6% | -82.1% |
| R&D Expense | $27.3M | +3.6% | +25.7% |
| SG&A Expense | $24.9M | -4.3% | -28.2% |
| Operating Income | -$44.3M | +2.5% | -594.1% |
| Interest Expense | $2.3M | +2.1% | -56.6% |
| Pre-tax Income | -$44.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $103.4M | -52.3% | +5.8% |
| Short-term Investments | $88.3M | +325.7% | — |
| Accounts Receivable | $9.2M | +81.0% | -94.5% |
| Inventory | $2.0M | -54.6% | -95.7% |
| Current Assets | $461.0M | +21.2% | +24.9% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$118.8M | — | — |
| Investing Cash Flow | $377.9M | — | — |
| Financing Cash Flow | -$281.8M | — | — |
| +0.8% |
| -314.1% |
| Net Income | -$35.5M | -111.9% | -230.5% |
| EPS (Basic) | -$0.31 | -112.1% | -244.4% |
| EPS (Diluted) | -$0.31 | -112.1% | -244.4% |
| $516.5M |
| +17.5% |
| +2.3% |
| Current Liabilities | $372.3M | +41.2% | +26.0% |
| Total Liabilities | $428.7M | +34.1% | -27.7% |
| Stockholders' Equity | $87.8M | -26.7% | +199.8% |